Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 03, 2024, titled "Alembic Pharmaceuticals receives US Food & Drug Administration (USFDA) product approvals (Final & Tentative) during the quarter ended 30th June, 2024.".